FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab

BACKGROUND: Polymorphisms of genes encoding the Fcy receptors (Fc fragment of IgG receptor 2A (FCGR2A) and 3A (FCGR3A)), which influence their affinity for the Fc fragment, have been linked to the pharmacodynamics of monoclonal antibodies. Most studies have been limited by small samples sizes and ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Kjersem, Janne B, Skovlund, Eva, Ikdahl, Tone, Guren, Tormod, Kersten, Christian, Dalsgaard, Astrid M, Yilmaz, Mette K, Fokstuen, Tone, Tveit, Kjell M, Kure, Elin H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045863/
https://www.ncbi.nlm.nih.gov/pubmed/24884501
http://dx.doi.org/10.1186/1471-2407-14-340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045863/
https://www.ncbi.nlm.nih.gov/pubmed/24884501
http://dx.doi.org/10.1186/1471-2407-14-340

Ejemplares similares